Insiders Updates Checking in on Sonoma Pharmaceuticals Inc (SNOA) after recent insiders movement In a filing, Sonoma Pharmaceuticals Inc revealed its 10% Owner Gottfurcht Grant acquired Company’s shares for reported $0.23 million on
Analysts Viewpoint Sonoma Pharmaceuticals Inc’s latest rating changes from various analysts Sonoma Pharmaceuticals Inc’s recently made public that its 10% Owner Gottfurcht Grant acquired Company’s shares for reported $0.23 million on
Featured Here’s the Reason of Sonoma Pharmaceuticals, Inc. (SNOA) Stock Gaining Momentum in Aftermarket. Sonoma Pharmaceuticals, Inc. (SNOA) is an innovative and leading global brand engaged in the development of stabilized hypochlorous acid products